(2S)-3-(t-butoxycarbonylamino)-2-(3,4-dimethoxy-benzyloxy)propanol 、 N-(5-chloropyridin-2-yl)-3-[2-hydroxy-4-methylthio-benzoylamino]pyridine-2-carboxamide 以gave the title compound as a solid (800 mg, 71%)的产率得到N-(5-chloropyridin-2-yl)-3-[4-methylthio-2-[(2S)-3-(t-butoxycarbonylamino)-2-(3,4-dimethoxybenzyloxy)propoxy]-benzoylamino]pyridine-2-carboxamide
This application relates to a compound of formula I (or a pro-drug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor (I).